Hope for Malaria Vaccine by 2015

British drug maker GlaxoSmithKline is seeking regulatory approval for the world’s first malaria vaccine after trial data showed that it had cut the number of cases in African children. Experts say that they are optimistic about the possibility of the world’s first vaccine after the trial results. Malaria, a mosquito-borne parasitic disease, kills hundreds of… Continue reading Hope for Malaria Vaccine by 2015

Malaria Vaccine Shows Early Promise in Clinical Trials

By Rebecca Morelle, BBC Science A malaria vaccine has shown promising results in early stage clinical trials, according to researchers. Researchers found the vaccine, which is being developed in the US, protected 12 out of 15 patients from the disease, when given in high doses. The method is unusual because it involves injecting live but… Continue reading Malaria Vaccine Shows Early Promise in Clinical Trials

Malaria Deaths Fall over 20% Worldwide in Last Decade

There has been a fall of just over 20% in the number of deaths from malaria worldwide in the past decade, the World Health Organization says. A new report said that one-third of the 108 countries where malaria was endemic were on course to eradicate the disease within 10 years. Experts said if targets continued… Continue reading Malaria Deaths Fall over 20% Worldwide in Last Decade

GlaxoSmithKline Malaria Vaccine Tests Show Hopeful Results

The quest for the world’s first malaria vaccine appears to have taken a big step: A study in Africa shows experimental shots cut the risk of disease in young children by half.

The initial results from a final stage of vaccine testing were released Tuesday, and the vaccine’s developers called it a milestone in helping to tame one of the world’s most devastating killers

Malaria Vaccine Trial Raises Hope

Researchers are to expand a clinical trial of a new malaria vaccine after promising results in a preliminary study in Burkina Faso.

The trial was designed to test safety, but researchers found that vaccinated children had high levels of protection.
Around a hundred different malaria vaccine candidates have been developed to date but the MSP3 vaccine tested in Burkina Faso is only the second one to show a substantial level of protection against the illness.

Using Mosquitoes To ‘Vaccinate’ Against Malaria

Joanne Silberner,NPR The parasite responsible for the intense fevers, chills, and headaches of malaria is very skilled at hiding in the in the body. That means vaccines don’t work all that well to prevent the disease. So Dutch researchers are trying a new approach — “vaccinating” people by having them get bitten by mosquitoes carrying… Continue reading Using Mosquitoes To ‘Vaccinate’ Against Malaria

Vaccine-Delivering Nanoparticles May Help Fight HIV, Malaria

Engineers at MIT have come up with a new type of nanoparticle that could safely and effectively deliver vaccines for diseases such as HIV and malaria. The new particles consist of concentric fatty spheres that can carry synthetic versions of proteins normally produced by viruses. These synthetic particles elicit a strong immune response – comparable… Continue reading Vaccine-Delivering Nanoparticles May Help Fight HIV, Malaria

Generic Malaria Drug Approval Granted to Glenmark Pharmaceuticals

The United States Food and Drug Administration (FDA) has granted Glenmark Pharmaceuticals final approval to sell a generic version of GlaxoSmithKline (GSK) malaria drug Malarone. In April 2010, Glenmark settled a patent litigation with GlaxoSmithKline over atovaquone and proguanil hydrochloride 250 milligram/100mg tablets–the generic version of Malarone. The Indian company can sell the generic tablets… Continue reading Generic Malaria Drug Approval Granted to Glenmark Pharmaceuticals